Analyze and develop Mainframe z/OS applications using PLI/JCL/DB2/CICS, MQ, CICS Web services. Design, develop and maintain... mainframe Pl1/CICS/Db2 applications. Participate in maintenance and On-call/on-duty as per the requirement of the Squad...
Summary We are actively seeking a self-motivated individual to join our team as an IBM DB2 Developer. In this role..., you will be responsible for designing and developing enhancements to software applications with a primary focus on IBM DB2 integration...
and responsibilities of developing distributive applications, utilizing COBOL, CICS, DB2, JCL, VSAM. Candidate must be team oriented... technologies such as COBOL, DB2, CICS, VSAM and JCL for Cigna Health Services / Evernorth Technology. Provide expertise, tools...
Strong expertise in mainframe - COBOL, DB2, IMS DB, VSAM, JCL troubleshooting skills using debugging tools. Able to provide support... scheduler. Develop and maintain transaction programs independently using DB2 and IMS DB Use Endevor for source code management...
Strong expertise in mainframe - COBOL, DB2, IMS DB, VSAM, JCL troubleshooting skills using debugging tools. Able to provide support... scheduler. Develop and maintain transaction programs independently using DB2 and IMS DB Use Endevor for source code management...
Indian benchmark indices continue bullish streak, fueled by potential rate cut by US Federal Reserve, FPI inflows, and rally in banking and IT stocks. Nifty 50 ends week with 1.30% gain, hitting new all-time high. Mid- and small-cap stocks also show strong performance. Continue Reading »
According to data collected from the Bombay Stock Exchange (BSE) website, the Emcure Pharmaceuticals IPO issue was oversubscribed 67.86 times. Qualified institutional buyers (QIB), non-institutional investors (NII), and retail investors showed strong bids on the third day. Continue Reading »
Anand Rathi recommends 2 'emerging picks' for July 2024, focusing on CONCOR and ideaForge Technology with a time horizon of 30-90 days. Continue Reading »
Stock Market Today: Sun Pharma share price has risen almost 25% year to date. The news flow recently has remained around regulatory actions by the USFDA for Dadra nd Halol plant Should you Buy , Sell or Hold the stock? Continue Reading »
Bansal Wire IPO subscription status shows overwhelming response from investors, with 59.57 times subscription. QIBs, NIIs, and retail investors actively participated. Price band set at ₹243-256 per share. Analysts bullish on long-term prospects, expecting decent listing gains of over 25%. Continue Reading »
V-Mart acquired Limeroad in FY23 to push its omnichannel strategy, but has been cutting costs to reduce Limeroad’s losses of late..Limeroad’s Ebitda loss in FY24 stood at ₹71.6 crore and V-Mart expects the FY25 loss to be 40-50% of that. Continue Reading »